Breast Development and Cancer

Martine Berliere^{1

2}, Francois P Duhoux^{1

3}, Aline François^{1

4}, Christine Galant^{1

4}

Affiliations

¹ Breast Clinic, King Albert II Cancer Institute, Cliniques Universitaires Saint-Luc, Avenue Hippocrate, 10, 1200 Brussels, Belgium.
² Department of Gynecology, King Albert II Cancer Institute, Cliniques Universitaires Saint-Luc, Avenue Hippocrate, 10, 1200 Brussels, Belgium.
³ Department of Medical Oncology, King Albert II Cancer Institute, Cliniques Universitaires Saint-Luc, Avenue Hippocrate, 10, 1200 Brussels, Belgium.
⁴ Department of Pathology, King Albert II, Cancer Institute, Cliniques Universitaires Saint-Luc, Avenue Hippocrate, 10, 1200 Brussels, Belgium.

Editorial

Martine Berliere et al. Cancers (Basel). 2023.

. 2023 Mar 13;15(6):1731.

doi: 10.3390/cancers15061731.

Martine Berliere^{1

2}, Francois P Duhoux^{1

3}, Aline François^{1

4}, Christine Galant^{1

4}

¹ Breast Clinic, King Albert II Cancer Institute, Cliniques Universitaires Saint-Luc, Avenue Hippocrate, 10, 1200 Brussels, Belgium.
² Department of Gynecology, King Albert II Cancer Institute, Cliniques Universitaires Saint-Luc, Avenue Hippocrate, 10, 1200 Brussels, Belgium.
³ Department of Medical Oncology, King Albert II Cancer Institute, Cliniques Universitaires Saint-Luc, Avenue Hippocrate, 10, 1200 Brussels, Belgium.
⁴ Department of Pathology, King Albert II, Cancer Institute, Cliniques Universitaires Saint-Luc, Avenue Hippocrate, 10, 1200 Brussels, Belgium.

Abstract

The human breast, as mentioned by Gudjonsson and co-authors [...].

The authors declare no conflict of interest.

1. Ingthorsson S., Traustadottir G.A., Gudjonsson T. Cellular Plasticity and Heterotypic Interactions during Breast Morphogenesis and Cancer Initiation. Cancers. 2022;14:5209. doi: 10.3390/cancers14215209. - DOI - PMC - PubMed
1. Berliere M., Coche M., Lacroix C., Riggi J., Coyette M., Coulie J., Galant C., Fellah L., Leconte I., Maiter D., et al. Effects of Hormones on Breast Development and Breast Cancer Risk in Transgender Women. Cancers. 2022;15:245. doi: 10.3390/cancers15010245. - DOI - PMC - PubMed
1. Rustighi A., Zannini A., Campaner E., Ciani Y., Piazza S., Del Sal G. PIN1 in Breast Development and Cancer: A Clinical Perspective. Cell Death Differ. 2017;24:200–211. doi: 10.1038/cdd.2016.122. - DOI - PMC - PubMed
1. Rana P.S., Wang W., Alkrekshi A., Markovic V., Khiyami A., Chan R., Perzynski A., Joseph N., Sossey-Alaoui K. YB1 Is a Major Contributor to Health Disparities in Triple Negative Breast Cancer. Cancers. 2021;13:6262. doi: 10.3390/cancers13246262. - DOI - PMC - PubMed
1. Shen Y., Singh J., Sah B., Chen Z., Ha W., Henzler C., Su T., Xie L., Deng Y., Li G., et al. The Histone Demethylase HR Suppresses Breast Cancer Development through Enhanced CELF2 Tumor Suppressor Activity. Cancers. 2022;14:4648. doi: 10.3390/cancers14194648. - DOI - PMC - PubMed